Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2015

01-06-2015 | Original Article

Insulin-related knowledge of health care professionals (HCPs) in a Nigerian tertiary health institution

Authors: Michael A. Olamoyegun, Sandra Omozehio Iwuala, Kehinde D. Olamoyegun, Olufunke O. Olaniregun, Babatope Kolawole

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2015

Login to get access

Abstract

Diabetes is a common disease, and increasing numbers of patients with it will be hospitalized. Insulin, a medication often prescribed in patients with diabetes on admission, is one of the commonest drugs with prescription and administration errors. This is related in part to poor knowledge of health care professionals (HCPs) of insulin, contributing to adverse patient outcomes. Different categories and cadres of HCPs were recruited to assess their knowledge of insulin names, characteristics, and inpatient insulin use among diabetic inpatients, utilizing a 20-item multiple choice question instrument. The study involved 179 HCPs: 84 doctors and 95 nurses. The response rate was 89 %. The overall mean knowledge scores were low: specialists achieved a mean (SD) score of 51 (17), residents 44 (18), interns 39 (14), and nurses 35 (11). Many HCPs in this study possessed a poor knowledge of insulin names, characteristics, and inpatient insulin use among hospitalized diabetics.
Literature
1.
go back to reference Masson EA, MacFarlane IA, Power E, Wallymahmed M. An audit of the management and outcome of hospital inpatients with diabetes: resource planning implications for the diabetes care team. Diabet Med. 1992;9:753–5.PubMedCrossRef Masson EA, MacFarlane IA, Power E, Wallymahmed M. An audit of the management and outcome of hospital inpatients with diabetes: resource planning implications for the diabetes care team. Diabet Med. 1992;9:753–5.PubMedCrossRef
2.
go back to reference Akinkugbe OO. Non-communicable diseases in Nigeria. Final report of a national survey. Federal ministry of Health and Social Services; 1997. Akinkugbe OO. Non-communicable diseases in Nigeria. Final report of a national survey. Federal ministry of Health and Social Services; 1997.
3.
go back to reference Ohwovoriole AE, Kuti JA, Kabiawu SI. Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos metropolis Nigerians. Diabetes Res Clin Pract. 1998;4(2):153–8.CrossRef Ohwovoriole AE, Kuti JA, Kabiawu SI. Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos metropolis Nigerians. Diabetes Res Clin Pract. 1998;4(2):153–8.CrossRef
4.
go back to reference Dahiru T, Jibo A, Hassan AA, Mande AT. Prevalence of diabetes in a semi-urban community in Northern Nigeria. 2008;17(4):414–16. Dahiru T, Jibo A, Hassan AA, Mande AT. Prevalence of diabetes in a semi-urban community in Northern Nigeria. 2008;17(4):414–16.
5.
go back to reference Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, Cooper RS. Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J. 1997;74(5):299–302.PubMed Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, Cooper RS. Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J. 1997;74(5):299–302.PubMed
6.
go back to reference Rotimi CN, Cooper RS, Okosun IS, Olatunbosun ST, Bella AF, Wilks R, et al. Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans and US blacks. Ethn Dis. 1999;9(2):190–200.PubMed Rotimi CN, Cooper RS, Okosun IS, Olatunbosun ST, Bella AF, Wilks R, et al. Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans and US blacks. Ethn Dis. 1999;9(2):190–200.PubMed
7.
go back to reference Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalence and its risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003;62(3):177–85.PubMedCrossRef Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalence and its risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003;62(3):177–85.PubMedCrossRef
8.
go back to reference Ogbera AO, Ohwovoriole AE, Soyebi O. Case fatality among diabetic in-patients. J Clin Sci. 2002;2:18–21. Ogbera AO, Ohwovoriole AE, Soyebi O. Case fatality among diabetic in-patients. J Clin Sci. 2002;2:18–21.
9.
go back to reference Ogbera AO, Chinenye S, Onyekwere A, Fasanmade O. Prognostic indices of diabetes mortality. Ethn Dis. 2007;17(4):721–5.PubMed Ogbera AO, Chinenye S, Onyekwere A, Fasanmade O. Prognostic indices of diabetes mortality. Ethn Dis. 2007;17(4):721–5.PubMed
10.
go back to reference Adekanle O, Ayodeji OO, Olatunde LO, Folorunso TR. A 7-year retrospective study of diabetes-related deaths in a Nigerian tertiary hospital. Mera Diabetes Int. 2008;16:15–7. Adekanle O, Ayodeji OO, Olatunde LO, Folorunso TR. A 7-year retrospective study of diabetes-related deaths in a Nigerian tertiary hospital. Mera Diabetes Int. 2008;16:15–7.
11.
go back to reference Chijokie A, Adamu AN, Makusidi AM. Mortality pattern among type 2 diabetes patients in Ilorin, Nigeria. JEMDSA. 2010;15(2):79–82. Chijokie A, Adamu AN, Makusidi AM. Mortality pattern among type 2 diabetes patients in Ilorin, Nigeria. JEMDSA. 2010;15(2):79–82.
12.
go back to reference Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac procedures. Ann Thorac Surg. 1999;67:352–60.PubMedCrossRef Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac procedures. Ann Thorac Surg. 1999;67:352–60.PubMedCrossRef
13.
go back to reference Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21.PubMedCrossRef Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21.PubMedCrossRef
15.
go back to reference Weston C, Walker L, Birkhead J, National Audit of Myocardial Infarction Project, National Institute of Clinical Outcomes Research. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart. 2007;93(12):1542–6.PubMedCentralPubMedCrossRef Weston C, Walker L, Birkhead J, National Audit of Myocardial Infarction Project, National Institute of Clinical Outcomes Research. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart. 2007;93(12):1542–6.PubMedCentralPubMedCrossRef
16.
go back to reference Marchant Jr MH, Viens NA, Cook C, Vail TP, Bolognosi MP. The impact of glycaemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;7:1621–9.CrossRef Marchant Jr MH, Viens NA, Cook C, Vail TP, Bolognosi MP. The impact of glycaemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;7:1621–9.CrossRef
17.
go back to reference Ogbera AO, Adeyemi-Doro A. Emotional distress is associated with poor self care in type 2 diabetes mellitus. J Diabetes. 2011;3:348–52.PubMedCrossRef Ogbera AO, Adeyemi-Doro A. Emotional distress is associated with poor self care in type 2 diabetes mellitus. J Diabetes. 2011;3:348–52.PubMedCrossRef
18.
go back to reference Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, et al. Profile of Nigerians with diabetes mellitus—Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab. 2012;16:558–64.PubMedCentralPubMedCrossRef Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, et al. Profile of Nigerians with diabetes mellitus—Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab. 2012;16:558–64.PubMedCentralPubMedCrossRef
19.
go back to reference Reid A. Changing practice for safe insulin administration. Nurs Times. 2012;108:22–6.PubMed Reid A. Changing practice for safe insulin administration. Nurs Times. 2012;108:22–6.PubMed
20.
go back to reference American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care. 2008;31:596–615.CrossRef American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care. 2008;31:596–615.CrossRef
21.
go back to reference Cox AR. Prescribing errors in diabetes. J Diabetes Vasc Dis. 2009;9:84–8.CrossRef Cox AR. Prescribing errors in diabetes. J Diabetes Vasc Dis. 2009;9:84–8.CrossRef
22.
go back to reference Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004;10:100–8.PubMedCrossRef Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004;10:100–8.PubMedCrossRef
23.
go back to reference Cohen M. ‘High alert’ medications and patient safety. Int J Qual Health Care. 2001;13(4):339–40. Cohen M. ‘High alert’ medications and patient safety. Int J Qual Health Care. 2001;13(4):339–40.
24.
go back to reference Department of health (England). Building a safer NHS for patients. Improving medication safety; 2004. Department of health (England). Building a safer NHS for patients. Improving medication safety; 2004.
25.
go back to reference United State Pharmacopeia. MEDMARX 5th anniversary data report. A chart book of 2003 findings and trends 1999–2003. Rockville: US Pharmacopeia. United State Pharmacopeia. MEDMARX 5th anniversary data report. A chart book of 2003 findings and trends 1999–2003. Rockville: US Pharmacopeia.
26.
go back to reference Kowiatek J, Skledar S, Potoski B. Insulin medication error reduction: a quality improvement initiative. Hosp Pharm. 2001;36(6):639–44. Kowiatek J, Skledar S, Potoski B. Insulin medication error reduction: a quality improvement initiative. Hosp Pharm. 2001;36(6):639–44.
27.
go back to reference Heatlie JM. Reducing insulin medication errors: evaluation of a quality improvement initiative. J Nurs Staff. 2003;19:92–8.CrossRef Heatlie JM. Reducing insulin medication errors: evaluation of a quality improvement initiative. J Nurs Staff. 2003;19:92–8.CrossRef
28.
go back to reference Grinssinger M, Kroon L, Penna P. Misadventures in insulin therapy: are your members at risk? J Manag Care Pharm. 2003;9(suppl):2–9. Grinssinger M, Kroon L, Penna P. Misadventures in insulin therapy: are your members at risk? J Manag Care Pharm. 2003;9(suppl):2–9.
29.
go back to reference Derr RL, Sivanandy MS, Bronich-Hall L, Rodriguez A. Insulin-related knowledge among health care professionals in internal medicine. Diabetes Spectr. 2007;20(3):177–85.CrossRef Derr RL, Sivanandy MS, Bronich-Hall L, Rodriguez A. Insulin-related knowledge among health care professionals in internal medicine. Diabetes Spectr. 2007;20(3):177–85.CrossRef
31.
go back to reference James J. Insulin-treated inpatients and prescribing errors. J Diabetes Nurs. 2005;9(5):201–25. James J. Insulin-treated inpatients and prescribing errors. J Diabetes Nurs. 2005;9(5):201–25.
Metadata
Title
Insulin-related knowledge of health care professionals (HCPs) in a Nigerian tertiary health institution
Authors
Michael A. Olamoyegun
Sandra Omozehio Iwuala
Kehinde D. Olamoyegun
Olufunke O. Olaniregun
Babatope Kolawole
Publication date
01-06-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0240-9

Other articles of this Issue 2/2015

International Journal of Diabetes in Developing Countries 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.